4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cohance Lifesciences Limited (COHANCE) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India. Its market capitalization is roughly ₹168 billion. In the fiscal year ended 2026-03-31, COHANCE reported ₹22.0B in revenue and ₹1.8B in net income.
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹22.0B | ₹25.3B | ₹10.3B | ₹13.3B | — |
| Gross Profit | ₹14.6B | ₹16.7B | ₹7.2B | ₹7.4B | — |
| Operating Income (EBIT) | ₹2.5B | ₹6.6B | ₹3.5B | ₹5.3B | — |
| Net Income | ₹1.8B | ₹4.9B | ₹3.0B | ₹4.1B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹4.2B | ₹6.2B | ₹5.4B | ₹5.6B | ₹5.5B | — |
| Gross Profit | ₹3.0B | ₹4.0B | ₹3.9B | ₹4.1B | ₹4.0B | — |
| Operating Income (EBIT) | (₹484M) | ₹474M | ₹484M | ₹769M | ₹669M | — |
| Net Income | (₹241M) | ₹196M | ₹367M | ₹741M | ₹489M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | (₹2.0B) | (₹1.0B) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹57.3B | ₹54.8B | ₹22.5B | ₹19.7B | — |
| Total Liabilities | ₹17.0B | ₹16.9B | ₹2.0B | ₹2.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COHANCE viewer.
About TickerBase · Data methodology & sources · Privacy · Terms